These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 4644164)

  • 1. Serum viscosity and hyperviscosity syndrome in IgG multiple myeloma. Report on 10 patients and a review of the literature.
    Pruzanski W; Watt JG
    Ann Intern Med; 1972 Dec; 77(6):853-60. PubMed ID: 4644164
    [No Abstract]   [Full Text] [Related]  

  • 2. A urinary cryo-Bence Jones protein gelling at room temperature.
    Harris RI; Kohn J
    Clin Chim Acta; 1974 Jun; 53(2):233-7. PubMed ID: 4841989
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple myeloma without initial paraproteins.
    Kim I; Harley JB; Weksler B
    Am J Med Sci; 1972 Oct; 264(4):267-75. PubMed ID: 4630526
    [No Abstract]   [Full Text] [Related]  

  • 4. Alternating appearance of IgD and IgG myeloma protein during treatment.
    Oxelius VA
    Scand J Haematol; 1971; 8(6):439-45. PubMed ID: 5160304
    [No Abstract]   [Full Text] [Related]  

  • 5. Heavy chain typing in IgG monoclonal gammopathies with special reference to cases of serum hyperviscosity and cryoglobulinaemia.
    Virella G; Hobbs JR
    Clin Exp Immunol; 1971 Jun; 8(6):973-80. PubMed ID: 4997073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperviscosity syndrome with IgA myeloma.
    Dine ME; Guay AT; Snyder LM
    Am J Med Sci; 1972 Aug; 264(2):111-5. PubMed ID: 4653114
    [No Abstract]   [Full Text] [Related]  

  • 7. Aggregation phenomenon in an IgG multiple myeloma resulting in the hyperviscosity syndrome.
    Benninger GW; Kreps SI
    Am J Med; 1971 Aug; 51(2):287-93. PubMed ID: 5095532
    [No Abstract]   [Full Text] [Related]  

  • 8. Myeloma proteins, Bence Jones proteins and normal immunoglobulins in multiple myeloma.
    Caggiano V; Cuttner J; Solomon A
    Blood; 1967 Sep; 30(3):265-87. PubMed ID: 6038301
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoclonal IgD. A comparative study of 60 sera with IgD "M" component.
    Fine JM; Rivat C; Lambin P; Ropartz C
    Biomedicine; 1974 Mar; 21(3):119-25. PubMed ID: 4429767
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperviscosity syndrome in multiple myeloma. A reversible, concentration-dependent aggregation of the myeloma protein.
    Lindsley H; Teller D; Noonan B; Peterson M; Mannik M
    Am J Med; 1973 May; 54(5):682-8. PubMed ID: 4701949
    [No Abstract]   [Full Text] [Related]  

  • 11. Two cases of gamma-D myeloma.
    Duggin GG; Penny R
    Aust N Z J Med; 1971 Feb; 1(1):72-5. PubMed ID: 5284088
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma cell myeloma with D-myeloma protein (IgD myeloma).
    Fahey JL; Carbone PP; Rowe DS; Bachmann R
    Am J Med; 1968 Sep; 45(3):373-80. PubMed ID: 4175067
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperviscosity syndrome associated with immunoglobulin A myeloma.
    Freel RJ; Maldonado JE; Gleich GJ
    Am J Med Sci; 1972 Aug; 264(2):117-22. PubMed ID: 4653115
    [No Abstract]   [Full Text] [Related]  

  • 14. Double spike in the electropherogram of a myeloma serum, from Bence Jones protein.
    Vladutiu AO; Kohli RK
    Clin Chem; 1977 Jan; 23(1):140-2. PubMed ID: 832364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy.
    Alexanian R; Migliore PJ
    J Lab Clin Med; 1970 Feb; 75(2):225-33. PubMed ID: 5414404
    [No Abstract]   [Full Text] [Related]  

  • 16. Isoelectric separation of urinary Bence Jones proteins and light chains of human IgG.
    Gerber H; Barandun S
    Immunochemistry; 1969 May; 6(3):469-71. PubMed ID: 5786937
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunocytoma o' mice an' men.
    Hobbs JR
    Br Med J; 1971 Apr; 2(5753):67-72. PubMed ID: 4101482
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens.
    Alexanian R; Haut A; Khan AU; Lane M; McKelvey EM; Migliore PJ; Stuckey WJ; Wilson HE
    JAMA; 1969 Jun; 208(9):1680-5. PubMed ID: 5818682
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the demonstration of Bence Jones proteins].
    Morell A; Gerber H; Lopez V; Barandun S
    Schweiz Med Wochenschr; 1969 Jun; 99(24):876-85 contd. PubMed ID: 4979333
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple myeloma. II. The value of melphalan.
    Bernard DB; Lynch SR; Bothwell TH; Bezwoda WR; Stevens K; Shulman G
    S Afr Med J; 1974 May; 48(24):1026-8. PubMed ID: 4835772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.